Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects

NCT05713773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Syndrome
Obesity

Interventions

DRUG: coated beads glucose (8 g) and caffeine anhydrous
DRUG: coated beads glucose (8 g) and caffeine anhydrous
DRUG: coated beads glucose (8 g) and caffeine anhydrous
DRUG: coated beads glucose (8 g)
DRUG: uncoated beads glucose (8 g) and caffeine anhydrous

Sponsor

Aphaia Pharma US LLC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]